Media
Our latest press releases and resources for media
Here you will find a range of resources including our latest and archived press releases, information on our social media channels, and our photo and video library.
Key information
2020 Full year and fourth quarter results announcement
We announced our full year and fourth quarter results for the period ended 31 December 2020 on Wednesday 3 February 2021.
Press releases for media
- GSK announces Dr Anne Beal to join the Board as Non-Executive Director
- GSK to support manufacture of Novavax’ COVID-19 vaccine
- Lilly, Vir Biotechnology and GSK announce positive topline data from the phase 2 BLAZE-4 trial evaluating bamlanivimab with VIR-7831 in low-risk adults with COVID-19
- GSK and Vir Biotechnology announce submission of Emergency Use Authorization request to FDA for VIR-7831 for the early treatment of COVID-19
GSK Twitter
-
GSK @GSK
We’re advancing TCR-T cell therapies, a new generation of oncology cell therapies, that have the potential to improve outcomes for patients with cancer with solid tumours. Learn more about our research in #oncology cell therapy at #AACR21.
about 6 hours ago -
GSK @GSK
At #AACR21, we’re sharing the latest research 🔬🧪🧬 from our immuno-oncology (I-O) pipeline. We continue to pioneer next-generation I-O therapies to improve outcomes for patients with cancer. #BehindTheSciencence to learn more.
about 11 hours ago
